---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-031995"
form_type: "8-K"
ticker: "TKNO"
cik: "0001850902"
company_name: "Alpha Teknova, Inc."
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T15:29:57.292861+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Teknova reports FY2024 revenue $37.7M (+3% YoY), guides FY2025 $39-42M, amends credit facility

## Summary
- FY2024 revenue $37.7M (+3% YoY); Q4 revenue $9.3M (+18% YoY). Clinical Solutions Q4 revenue $1.85M (+110% YoY).
- Net loss FY2024 $26.7M ($0.57/share) vs $36.8M ($1.16) in FY2023; adjusted EBITDA -$14.5M vs -$19.8M.
- 2025 guidance: revenue $39-42M, free cash outflow <$12M (vs -$13.5M in FY2024).
- New $28.245M credit facility ($23.245M term + $5M revolver), maturity March 2030, principal pay starting April 2028.
- Covenants: minimum net revenue $39M for TTM ending Dec 2025; minimum cash $8M.

## SEC filing metadata
- accession: 0000950170-25-031995
- form_type: 8-K
- ticker: TKNO
- cik: 0001850902
- company_name: Alpha Teknova, Inc.
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850902/000095017025031995/0000950170-25-031995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850902/000095017025031995/tkno-20250304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-031995
- JSON: https://secwatch.observer/filing/0000950170-25-031995.json
- Plain text: https://secwatch.observer/filing/0000950170-25-031995.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.